FDA Inspection 1278466 — Frontage Laboratories (Suzhou) Co.,Ltd.
The FDA completed an inspection of Frontage Laboratories (Suzhou) Co.,Ltd. on May 9, 2025 in Suzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 9, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Suzhou (China)
Additional Details
Bioanalytical BA/BE